The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
1 lozenge contains Dequalinium Chloride calculated to 100 % substance 0.25 mg, Dibucaine hydrochloride calculated to 100 % substance 0.03 mg.
Local treatment of acute painful inflammatory infections of mouth and throat: gingivitis, ulcerative and aphtous stomatitis, tonsillitis, laryngitis and pharyngitis. LARYTYLEN also recommended for treatment of bad breath. LARYTYLEN could be used in cases of mixed infections of mouth and pharynx (under doctor`s prescription); as adjuvant treatment in angina catarrhalis, angina lacunaris and Paul-Vincent’s angina; candidiasis of mouth or throat. It is recommended in postsurgical period after tonsillectomy and dental extractions.
If you have information about any adverse effects or other drug-related problems, please fill in the form